ABVC - ABVC BIOPHARMA, INC.
1.27
0.120 9.449%
Share volume: 298,448
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.15
0.12
0.10%
View ratios
Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | |
Report Date | 05-17-2024 | 08-14-2023 | 11-15-2023 | 11-14-2024 | 05-17-2024 | 08-14-2024 | 11-14-2024 | 04-30-2025 | |
Total revenue | 150.372 K | 6.109 K | 15.884 K | 45.965 K | 1.205 K | 117.620 K | 401.276 K | 12.000 K | |
Cost of revenue | 60.236 K | 72.981 K | 29.614 K | 139.206 K | 277.000 | 190.000 | 296.000 | 0.000 | |
Gross profit | 68.036 K | -66.872 K | -13.730 K | -137.041 K | 928.000 | 116.952 K | 388.980 K | 0.000 | |
-198.29% | 79.47% | -898.11% | 100.68% | 12,502.59% | 232.60% | -100.00% | |||
Operating expenses | 1.608 M | 1.901 M | 1.323 M | 1.599 M | 900.323 K | 680.852 K | 339.033 K | 644.232 K | |
Selling general and admin | 1.273 M | 1.387 M | 1.182 M | 1.527 M | 831.257 K | 640.451 K | 301.208 K | 615.371 K | |
Research and development | 334.979 K | 514.442 K | 141.310 K | 72.185 K | 69.066 K | 40.401 K | 37.825 K | 28.861 K | |
Total expenses | 1.974 M | 2.127 M | 2.141 M | -316.574 K | 3.445 M | 1.094 M | 339.033 K | 693.005 K | |
7.74% | 0.67% | -114.79% | 1,188.31% | -68.26% | -69.00% | 104.41% | |||
Operating income | -1.906 M | -2.194 M | -2.155 M | -1.962 M | -3.444 M | -976.641 K | 49.947 K | -693.005 K | |
Ebit | -1.915 M | -2.209 M | -2.191 M | -633.797 K | -3.300 M | -1.151 M | 97.240 K | -701.417 K | |
Pretax income | -1.897 M | -2.234 M | -3.369 M | -3.154 M | -3.981 M | -1.384 M | -133.917 K | -944.190 K | |
17.73% | 50.84% | -6.37% | 26.20% | -65.25% | -90.32% | 605.06% | |||
Income tax | 0.000 | 81.695 K | -999.000 | 175.310 K | 0.000 | -110.894 K | 355.000 | 0.000 | |
Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income | -1.897 M | -2.315 M | -3.368 M | -12.237 K | -3.981 M | -1.273 M | -134.272 K | -944.190 K | |
-22.03% | -45.48% | 99.64% | -32,432.64% | 68.03% | 89.45% | -603.19% |